

Biocon Pharma Profile
Key Indicators
- Authorised Capital ₹ 1,040.15 Cr
- Paid Up Capital ₹ 887.10 Cr
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 133.00 Cr
- Revenue Growth -1.30%
- Profit Growth -57.20%
- Ebitda -13.16%
- Net Worth 38.03%
- Total Assets 107.65%
About Biocon Pharma
Biocon Pharma Limited (BPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 31 October 2014 and has a history of Ten years and six months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1,040.15 Cr and a paid-up capital of Rs 887.10 Cr.
The company has closed loans amounting to ₹133.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biocon Pharma Limited India are Mayank Verma as COMPANY SECRETARY and Soudabi Neduvanchery as Cfo. Kiran Shaw, Siddharth Mittal, and Karaikal Krishnan serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232KA2014PLC077036
- Company No.
077036
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2014
- Date of AGM
09 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Biocon Pharma?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mayank Verma ![]() | Company Secretary | 22-Oct-2020 | Current |
Soudabi Neduvanchery | CFO | 29-Aug-2024 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kiran Shaw ![]() | Director | 31-Oct-2014 | Current |
Siddharth Mittal ![]() | Whole-Time Director | 23-Jan-2020 | Current |
Karaikal Krishnan ![]() | Director | 13-May-2022 | Current |
Financial Performance of Biocon Pharma.
Biocon Pharma Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.3% decrease. The company also saw a substantial fall in profitability, with a 57.2% decrease in profit. The company's net worth Soared by an impressive increase of 38.03%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Biocon Pharma?
In 2023, Biocon Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Science Gallery Bengaluru
Kiran Shaw is a mutual person
- Mazumdar Shaw Medical Foundation
Kiran Shaw is a mutual person
- Immuneel Therapeutics Private Limited
Kiran Shaw is a mutual person
- Trent Limited
Kiran Shaw is a mutual person
- Csep Research Foundation
Kiran Shaw is a mutual person
- Biocon Academy
Kiran Shaw and Siddharth Mittal are mutual person
Charges (Loans)
₹0
₹133.00 Cr
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 133.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Sep 2016 | Citi Bank N.A. | ₹133.00 Cr | Satisfied |
How Many Employees Work at Biocon Pharma?
Biocon Pharma has a workforce of 526 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Biocon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon Pharma's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Biocon Pharma
Recent activity within the organization
- Director Appointment
Soudabi Neduvanchery was appointed as a Cfo was appointed as a Cfo on 29 Aug 2024 & has been associated with this company since 8 months 26 days .
- Annual General Meeting
Biocon Pharma Limited last Annual general meeting of members was held on 09 Aug 2024 as per latest MCA records.
- Balance Sheet
Biocon Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.
- Charges
A charge registered on 29 Sep 2016 via Charge ID 100057801 with Citi Bank N.A. was fully satisfied on 31 May 2022.
- Director Appointment
Karaikal Narayanaswamy Murali Krishnan was appointed as a Director was appointed as a Director on 13 May 2022 & has been associated with this company since 3 years 13 days .
- Director Appointment
Mayank Verma was appointed as a Company Secretary was appointed as a Company Secretary on 22 Oct 2020 & has been associated with this company since 4 years 7 months .
Recent News, Updates & Announcement
- Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada.
Biocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalmology product for neovascular and age-related macular degeneration, in Canada by July 1, 2025..
- Biocon CFO Indranil Sen resigns.
Sen was appointed as the CFO of the company in April 2021 after Anupam Jindal stepped down. He has over 20 years of experience in financial planning, treasury, taxation and financial reporting..
Frequently asked questions
What is the Incorporation or founding date of Biocon Pharma Limited?
Biocon Pharma Limited was incorporated on 31 Oct 2014.
What is authorized share capital and paid-up capital of Biocon Pharma Limited?
The authorized share capital of Biocon Pharma Limited is ₹ 1,040.15 Cr and paid-up capital is ₹ 887.10 Cr.
Who are the current board members & directors of Biocon Pharma Limited?
Currently 5 directors are associated with Biocon Pharma Limited.
- Kiran Mazumdar Shaw
- Siddharth Mittal
- Karaikal Narayanaswamy Murali Krishnan
- Mayank Verma
- Soudabi Neduvanchery
What is the registered address of Biocon Pharma Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Biocon Pharma Limited is 20Km Electronics City, Hosur Road - India, Bangalore, Karnataka, 560100.
What is the corporate identification number (CIN) and company number of Biocon Pharma Limited?
The corporate identification number (CIN) of Biocon Pharma Limited is U24232KA2014PLC077036 and the company number is 077036 as per Ministry of Corporate Affairs (MCA).
What is the official website of Biocon Pharma Limited?
The Official website of Biocon Pharma Limited is https://www.biocon.com
What has been the recent revenue trend for Biocon Pharma Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Biocon Pharma Limited has fallen by -1.30%.
How many employees does Biocon Pharma Limited currently have?
As Per 2023 financial reports, 526 employees are currently employed by Biocon Pharma Limited.
What change has been observed in the net worth of Biocon Pharma Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Biocon Pharma Limited has experienced an upsurge of 38.03%.
When was the last Balance Sheet of Biocon Pharma Limited filed with the ROC?
The most recent Balance Sheet for Biocon Pharma Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Vijay KuchrooDirector
- John ShawDirector
AC
Arun ChandavarkarDirector and Chief Executive OfficerJW
John WallsDirector
Similar Companies Based on Drug Formulation & Development
- Mylan Laboratories Limited Hyderabad, Telangana, India
- Sun Pharma Laboratories Limited Vadodara, Gujarat, India
- Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
- Lupin Limited Mumbai, Maharashtra, India
- Alkem Laboratories Limited Mumbai, Maharashtra, India
- Hetero Labs Limited Rangareddy, Telangana, India
- Aurobindo Pharma Ltd Hyderabad, Telangana, India
- Cipla Limited Mumbai, Maharashtra, India